Skip to main
BLLN

Billiontoone Inc (BLLN) Stock Forecast & Price Target

Billiontoone Inc (BLLN) Analyst Ratings

Based on 7 analyst ratings
Buy
Strong Buy 43%
Buy 29%
Hold 29%
Sell 0%
Strong Sell 0%

Bulls say

BillionToOne Inc has demonstrated impressive revenue growth, achieving a year-over-year increase of 117% in its first quarter as a public company, along with a positive net income of $1.5 million for the first time in its history. The company's gross margins improved significantly to 53.0% in 2024, reflecting effective scaling and operational efficiency. Additionally, strong performance in both prenatal testing and oncology, highlighted by a 102% increase in prenatal test revenue and a staggering 664% increase in oncology revenue, underscores the potential for continued growth and a projected revenue compound annual growth rate (CAGR) of over 25% in the reproductive health sector.

Bears say

BillionToOne Inc faces a challenging outlook due to potential weaknesses in its competitive position if it cannot adequately protect its proprietary technology, which may impact future revenue streams. Additionally, the company may experience decreased reimbursement under the Clinical Laboratory Fee Schedule (CLFS) as rates are implemented, further pressuring its financial performance. This is compounded by higher denial rates from payers regarding the efficacy of its tests, leading to slower-than-expected revenue growth from both its core prenatal testing business and its recently launched oncology tests.

Billiontoone Inc (BLLN) has been analyzed by 7 analysts, with a consensus rating of Buy. 43% of analysts recommend a Strong Buy, 29% recommend Buy, 29% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Billiontoone Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Billiontoone Inc (BLLN) Forecast

Analysts have given Billiontoone Inc (BLLN) a Buy based on their latest research and market trends.

According to 7 analysts, Billiontoone Inc (BLLN) has a Buy consensus rating as of Mar 21, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $129.57, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $129.57, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Billiontoone Inc (BLLN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.